Guardant Health
GH
#2597
Rank
NZ$9.08 B
Marketcap
$73.61
Share price
4.01%
Change (1 day)
138.86%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -NZ$0.73 Billion

According to Guardant Health 's latest financial reports the company's current earnings are NZ$0.73 Billion. , an increase over its 2023 earnings that were of -NZ$0.84 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.76 Billion-9.12%
2023 -NZ$0.84 Billion-26.73%
2022 -NZ$1.14 Billion69.96%
2021 -NZ$0.67 Billion56.35%
2020 -NZ$0.43 Billion252.69%
2019 -NZ$0.13 Billion-17.22%
2018 -NZ$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.37 Billion-51.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.88 Billion 15.93%๐Ÿ‡บ๐Ÿ‡ธ USA